|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.470
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.430
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.406
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.272
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.248
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.224
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.190
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.169
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.164
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.161
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.130
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.115
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.100
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.099
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.095
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.093
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.085
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.085
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.081
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.080
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.076
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.075
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.074
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.072
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.069
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.069
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.068
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.064
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.063
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.062
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.062
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.062
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.061
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.061
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.061
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.060
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.057
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.055
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.053
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.053
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.052
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.052
|
|
|
organ regeneration
|
GO:0031100 |
2 |
0.051
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.051
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.050
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.050
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.050
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.049
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.049
|
|
|
cation transport
|
GO:0006812 |
399 |
0.048
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.048
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.047
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.047
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.046
|
|
|
regulation of triglyceride metabolic process
|
GO:0090207 |
17 |
0.045
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.045
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.043
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.042
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.042
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.042
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.042
|
|
|
diacylglycerol biosynthetic process
|
GO:0006651 |
2 |
0.040
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.040
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.039
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.039
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.038
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.038
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.038
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.037
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.037
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.035
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.035
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.034
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.034
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.034
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.033
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.033
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.033
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.033
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.032
|
|
|
gland development
|
GO:0048732 |
330 |
0.032
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.031
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.031
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.030
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.030
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.030
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.030
|
|
|
anion transport
|
GO:0006820 |
177 |
0.030
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.030
|
|
|
positive regulation of sequestering of triglyceride
|
GO:0010890 |
4 |
0.029
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.029
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.029
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.029
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.029
|
|
|
diacylglycerol metabolic process
|
GO:0046339 |
6 |
0.028
|
|
|
acylglycerol biosynthetic process
|
GO:0046463 |
18 |
0.028
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.028
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.028
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.027
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.027
|
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.027
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.027
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.027
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.027
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.027
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.027
|
|
|
dibenzo p dioxin metabolic process
|
GO:0018894 |
1 |
0.027
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.027
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.027
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.026
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.026
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.026
|
|
|
protein processing
|
GO:0016485 |
163 |
0.026
|
|
|
keratinocyte migration
|
GO:0051546 |
3 |
0.025
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.025
|
|
|
neutral lipid biosynthetic process
|
GO:0046460 |
18 |
0.025
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.024
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.024
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.024
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.024
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.024
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.024
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.024
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.023
|
|
|
amide transport
|
GO:0042886 |
138 |
0.023
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.023
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.023
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.023
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.022
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.022
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.022
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.022
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.022
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.022
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.022
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.021
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.021
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.021
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.021
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.021
|
|
|
regulation of protein kinase c activity
|
GO:1900019 |
1 |
0.021
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.021
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.021
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.020
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.020
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.020
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.020
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.020
|
|
|
norepinephrine epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001994 |
3 |
0.020
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.020
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.020
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.020
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.020
|
|
|
glucocorticoid metabolic process
|
GO:0008211 |
9 |
0.020
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.019
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.019
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.019
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.019
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.019
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.019
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.019
|
|
|
positive regulation of t cell mediated cytotoxicity
|
GO:0001916 |
15 |
0.019
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.019
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.019
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.019
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.019
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.019
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.019
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.019
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.019
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.019
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.019
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.019
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.019
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.019
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.019
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.018
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.018
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.018
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.018
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.018
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.018
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.018
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.018
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.018
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.018
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.018
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.018
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.018
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.018
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.018
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.018
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.017
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.017
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.017
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.017
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.017
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.017
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.017
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.017
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.017
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.017
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.017
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.017
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.017
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.017
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.017
|
|
|
regulation of glycogen catabolic process
|
GO:0005981 |
2 |
0.017
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.016
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.016
|
|
|
glycerolipid catabolic process
|
GO:0046503 |
16 |
0.016
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.016
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.016
|
|
|
short chain fatty acid catabolic process
|
GO:0019626 |
2 |
0.016
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.016
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.016
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.016
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.016
|
|
|
positive regulation of protein kinase c activity
|
GO:1900020 |
1 |
0.016
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.016
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.016
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.016
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.016
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.016
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.016
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.016
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.016
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.016
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.016
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.016
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.016
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.016
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.016
|
|
|
protein homooligomerization
|
GO:0051260 |
43 |
0.016
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.016
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.016
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.016
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.016
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.016
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.016
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.015
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.015
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.015
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.015
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.015
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.015
|
|
|
proton transport
|
GO:0015992 |
35 |
0.015
|
|
|
renal system process
|
GO:0003014 |
48 |
0.015
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.015
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.015
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.015
|
|
|
baroreceptor response to increased systemic arterial blood pressure
|
GO:0001983 |
3 |
0.015
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.015
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.015
|
|
|
positive regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014068 |
20 |
0.015
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.015
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.015
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.015
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.015
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.015
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.015
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.015
|
|
|
positive regulation of fatty acid metabolic process
|
GO:0045923 |
8 |
0.015
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.014
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.014
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.014
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.014
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.014
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.014
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.014
|
|
|
lung development
|
GO:0030324 |
164 |
0.014
|
|
|
negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure
|
GO:0001985 |
1 |
0.014
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.014
|
|
|
exogenous drug catabolic process
|
GO:0042738 |
1 |
0.014
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.014
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.014
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.014
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.014
|
|
|
long chain fatty acid metabolic process
|
GO:0001676 |
26 |
0.014
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.014
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.014
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.014
|
|
|
liver development
|
GO:0001889 |
66 |
0.014
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.014
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.014
|
|
|
cognition
|
GO:0050890 |
149 |
0.014
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
18 |
0.013
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.013
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.013
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.013
|
|
|
white fat cell differentiation
|
GO:0050872 |
15 |
0.013
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.013
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.013
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.013
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.013
|
|
|
negative regulation of heart rate
|
GO:0010459 |
4 |
0.013
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.013
|
|
|
ear development
|
GO:0043583 |
200 |
0.013
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.013
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.013
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.013
|
|
|
response to drug
|
GO:0042493 |
75 |
0.013
|
|
|
negative regulation of lipid catabolic process
|
GO:0050995 |
6 |
0.013
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.013
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.013
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.013
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.013
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.013
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.013
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.013
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.013
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.013
|
|
|
disruption of cells of other organism involved in symbiotic interaction
|
GO:0051818 |
13 |
0.013
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.013
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.013
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.013
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.013
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.012
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.012
|
|
|
triglyceride biosynthetic process
|
GO:0019432 |
17 |
0.012
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.012
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.012
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.012
|
|
|
regulation of fatty acid biosynthetic process
|
GO:0042304 |
12 |
0.012
|
|
|
negative regulation of execution phase of apoptosis
|
GO:1900118 |
4 |
0.012
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.012
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.012
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.012
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.012
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.012
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.012
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.012
|
|
|
fatty acid catabolic process
|
GO:0009062 |
25 |
0.012
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.012
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.012
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.012
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.012
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.012
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.012
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.012
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.012
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.012
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.012
|
|
|
cellular transition metal ion homeostasis
|
GO:0046916 |
32 |
0.012
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.012
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.012
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.012
|
|
|
response to glucocorticoid
|
GO:0051384 |
20 |
0.012
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.012
|
|
|
female meiosis chromosome segregation
|
GO:0016321 |
1 |
0.012
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.012
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.011
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.011
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.011
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.011
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.011
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.011
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.011
|
|
|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
4 |
0.011
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.011
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.011
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
0.011
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.011
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.011
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.011
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.011
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.011
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.011
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.011
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.011
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.011
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.011
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.011
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.011
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.011
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.011
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.011
|
|
|
long chain fatty acid import
|
GO:0044539 |
2 |
0.011
|
|
|
regulation of intestinal cholesterol absorption
|
GO:0030300 |
4 |
0.011
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.011
|
|
|
retinol metabolic process
|
GO:0042572 |
9 |
0.011
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.011
|
|
|
renal tubular secretion
|
GO:0097254 |
2 |
0.011
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.011
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.011
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.011
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.011
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.011
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.011
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.011
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.011
|
|
|
action potential
|
GO:0001508 |
78 |
0.011
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.011
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.010
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.010
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.010
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.010
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.010
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.010
|
|
|
protein homotrimerization
|
GO:0070207 |
4 |
0.010
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.010
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.010
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.010
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.010
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.010
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.010
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.010
|
|
|
negative regulation of gluconeogenesis
|
GO:0045721 |
9 |
0.010
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.010
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.010
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.010
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.010
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.010
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.010
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.010
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.010
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.010
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.010
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.010
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.010
|
|